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Polychlorinated biphenyls (PCBs), poly-
chlorinated dibenzo-p-dioxins (PCDDs),
polychlorinated dibenzofurans (PCDFs), and
p,p´-diphenyldichloroethene (DDE) are wide-
spread persistent environmental contami-
nants. Although human body burdens of these
chemicals have been decreasing over time
(Hagmar et al. 2006; Schecter et al. 2005),
they remain detectable in most of the popula-
tion due to their long half-life in the body
(Geyer et al. 2002) and continued exposure
primarily through the food supply (Needham
et al. 2005). 
Organochlorines have been associated with
a number of health effects, including disrup-
tion of thyroid hormone homeostasis. Thyroid
hormones are under control of the hypothal-
amo–pituitary–thyroid (HPT) axis. Reduction
of circulating thyroxine (T4) is compensated
for by release of thyroid-stimulating hormone
(TSH) from the pituitary, which in turn stim-
ulates the thyroid to produce more hormones.
In animals, PCBs and dioxin-like compounds
disrupt the HPT axis, decreasing thyroxine lev-
els and causing inconsistent changes in TSH
(Brouwer et al. 1990; Fisher et al. 2006;
van Birgelen et al. 1992, 1995). Dioxin-like
chemicals are thought to accomplish this
through binding to the aryl hydrocarbon
receptor (AhR), which induces uridine diphos-
phate glucuronosyltransferase enzymes, leading
to increased glucuronidation and excretion of
T4 (Fisher et al. 2006; van Birgelen et al.
1995). Ortho-substituted PCBs, which do not
bind to the AhR, disrupt the HPT axis
through other mechanisms which may include
increased glucuronidation through non AhR
pathways, displacement of T4 from the bind-
ing protein transthyretin, and direct effects on
TSH release from the pituitary (Brouwer et al.
1990; Khan et al. 2002; van Birgelen et al.
1992, 1995). 
The effects of organochlorines on thyroid
hormone homeostasis have been studied in
humans, but results have not been consistent.
Most investigations of endocrine disruption
by PCBs, PCDDs, PCDFs, and DDE in
humans have focused on populations with
higher exposures due to occupation or resi-
dence near areas contaminated by industry
(Calvert et al. 1999; Langer et al. 1998, 2004;
Osius et al. 1999; Ott et al. 1994; Pavuk et al.
2003; Persky et al. 2002; Schell et al. 2004;
Triebig et al. 1998), accident (Murai et al.
1987), or fish consumption (Hagmar et al.
2001a, 2001b; Langer et al. 2007; Persky
et al. 2001; Rylander et al. 2006; Turyk et al.
2006a). General population exposures have
also been associated with thyroid disruption
(Meeker et al. 2007; Takser et al. 2005),
although studies have not usually been popu-
lation based. A number of factors may be
related to the inconsistent human findings,
including different detection methods for bio-
markers and endogenous hormones, varying
overall exposure levels and concomitant
chemical exposures, as well as differences in
age, sex, nutritional status, comorbidities, and
medication use. 
In this study, we examined the effects of
low-level general population organochlorine
exposures on endogenous thyroid hormones
in a population without reported thyroid
disease. The National Health and Nutrition
Examination Survey (NHANES) is a cross-sec-
tional survey examining a random sample rep-
resentative of the U.S. population [Centers for
Disease Control and Prevention (CDC) 2007]. 
During the 1999–2000 and 2001–2002 survey
rounds, PCB, PCDD, and PCDF congeners;
DDE; total T4; and TSH were measured in
approximately one-third of the NHANES
sample. Data on individual organochlorine
congeners have been presented in the Third
National Report on Human Exposure to
Environmental Chemicals (CDC 2005) and
by Needham et al. (2005). This article focuses
on the cross-sectional relationships of PCB,
dioxin-like toxic equivalent (TEQ), and DDE
body burdens with T4 and TSH serum levels
in these two NHANES samples. 
Methods
Participants. Data from NHANES survey
cycles conducted in 1999–2000 and
2001–2002 were obtained online (CDC
2007). During these two data collection
cycles, total T4, TSH, DDE, and PCB,
PCDD, and PCDF congeners were measured
in serum sampled from one-third of the par-
ticipants. This subsample is also a nationally
representative sample of the U.S. population
(CDC 2007). Participants < 20 years of age
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BACKGROUND: Thyroid hormone homeostasis can be disrupted by exposure to ubiquitous and
bioaccumulative organochlorines such as polychlorinated biphenyls (PCBs) and polychlorinated
dibenzo-p-dioxins (PCDDs). Whereas investigations of health effects have generally focused on
human populations with relatively high exposures through occupation, accident, or high ﬁsh con-
sumption, general population exposures may also carry risk. 
METHODS: We studied associations of total thyroxine (T4) and thyroid-stimulating hormone
(TSH) with PCBs, dioxin-like toxic equivalents (TEQs), and p,p´-diphenyldichloroethene (DDE)
in adult participants without thyroid disease who participated in the 1999–2002 National Health
and Nutrition Examination Survey, a cross-sectional survey examining a random sample representa-
tive of the U.S. population. 
RESULTS: We found inverse associations of total T4 with exposure to TEQs in both sexes, with
stronger associations in females. In women, mean T4 was 8.2 µg/dL, and levels were on average
0.75 µg/dL lower (95% conﬁdence interval, 0.04–1.46) in women in the highest quintile of TEQ
exposure compared with the lowest two quintiles. Effects were stronger in people > 60 years of age,
with negative associations of T4 with PCBs and TEQs, and positive associations of TSH with
PCBs and TEQs in older women, and a negative association of TSH with PCBs in older men. 
CONCLUSIONS: The data show a dose-dependent decrease in total T4 with exposure to TEQs at
levels similar to those found in the general U.S. population. The effects were stronger in women.
The results suggest that older adults, who have a high risk of thyroid disease, may be more at
risk for disruption of thyroid hormone homeostasis by dioxin-like organochlorines than
younger adults.
KEY WORDS: CDC, Centers for Disease Control and Prevention, DDE, dioxin, endocrine disrup-
tion, furan, National Health and Nutrition Examination Survey, NHANES, PCB, thyroid, thyroid-
stimulating hormone, thyroxine, toxic equivalents, TSH. Environ Health Perspect 115:1197–1203
(2007). doi:10.1289/ehp.10179 available via http://dx.doi.org/ [Online 31 May 2007]were not tested for PCDD and PCDF con-
gener data during the 2001–2002 cycle; as a
result, they were excluded from the analysis.
After exclusion of participants for which we
did not have both organochlorine and thyroid
hormone measurements and those who were
diagnosed with current thyroid disease or who
used thyroid medication (n = 150; 36 men
and 114 women), a total of 995 participants
for the 1999–2000 cycle and 1,450 partici-
pants for the 2001–2002 cycle were available
for analysis of the associations of thyroid hor-
mones with organochlorine body burdens. We
were not able to examine associations of diag-
nosed hypothyroidism with organochlorines
because the survey questions relating to thy-
roid conditions did not distinguish between
different types of thyroid diseases. 
Thyroid hormones. Total T4 (micrograms
per deciliter) and TSH (international units per
liter) were measured in serum by two different
laboratories. Sera collected during the
1999–2000 cycle and part of the 2001–2002
cycle were measured by the Coulston
Foundation (Alamogordo, NM), whereas the
remainder of samples from the 2001–2002
cycle were tested at Collaborative Laboratory
Services (Ottumwa, IA). The National Center
for Health Statistics evaluated the 2001–2002
TSH and T4 data sets from the two laborato-
ries and determined that the variables were
comparable across the 2 years (Blount et al.
2006). Total T4 was measured on a Hitachi
704 chemistry analyzer (Coulston Foundation)
and by a paramagnetic particle, chemilumines-
cent, competitive binding enzyme immuno-
assay (Collaborative Laboratory Services)
(CDC 2007e). TSH was measured by an IMx
ultrasensitive hTSH II microparticle enzyme
immunoassay (Coulston Foundation) and by
a two-site, paramagnetic particle and chemilu-
minescent immunoassay (Collaborative
Laboratory Services) (CDC 2007d). Both
laboratories reported a reference range of
5.4–12.8 µg/dL for total T4. Reference ranges
for TSH were 0.47–5.0 IU/L for the
Coulston Foundation and 0.24–5.4 IU/L for
Collaborative Laboratory Services. 
PCB, PCDD, PCDF, and DDE measure-
ments. Organochlorines were measured in
serum by high-resolution gas chromatography/
isotope-dilution high-resolution mass spec-
trometry (Organic Toxicology Branch,
National Center for Environmental Health,
CDC, Atlanta, GA) (CDC 2007b, 2007c).
We created a variable for total PCBs (ΣPCBs)
by summing individual PCB congeners. TEQs
were calculated for each PCDD, PCDF, copla-
nar PCB, and mono-ortho PCB congener by
multiplying the toxic equivalency factor by the
congener concentration in picograms per gram
(Van den Berg et al. 2006) and then summing
the values to calculate total TEQs (ΣTEQs).
For congeners with results below the limit of
detection (LOD), the CDC imputed the value
for the congener as the LOD for that speciﬁc
congener divided by the square root of 2. The
LOD varied for each participant, as it was
dependent on the volume of the sample sub-
mitted for analysis. In the ﬁrst sampling cycle
(1999–2000), fewer congeners were measured
and more individual results were below the
LOD, compared with the second cycle
(Table 1). Only congeners that had > 10% of
results > LOD were included in the ΣPCBs
and ΣTEQs; therefore, the speciﬁc congeners
in the ΣPCBs and ΣTEQs differed in the two
sampling cycles (Table 1). When results for
more than one congener were not reported by
the CDC for a participant, the participant was
coded as missing for ΣPCBs or ΣTEQs.
Covariates. We considered medications
that can alter hormone homeostasis (Meier
and Burger 2005) to be potential effect modi-
fiers or confounders of the associations of
organochlorines on thyroid hormones.
Medications were identified in the prescrip-
tion drug medication and the analgesics/pain
reliever questionnaires, and included estrogens
and/or progesterone, other steroid hormones
(androgens, adrenal corticosteroids, tamoxifen,
raloxifene, and pituitary hormones), non-
steroidal anti-inﬂammatory drugs (NSAIDs),
furosemide, beta-blockers, blood glucose regu-
lators, and other medications thought to affect
thyroid hormones (amidoarone, carbamaze-
pine, chlorpropamide, carbidopa/levodopa,
heparin, interferon, lithium, phenytoin,
phenobarbital, and sulfasalazine). Because
estrogen alters total thyroxine-binding globulin
concentrations, we also considered current
pregnancy and menopausal status to be poten-
tial confounders or effect modiﬁers. Smoking
can affect thyroid hormone levels through the
metabolism of cyanide in smoke to thio-
cyanate, a potent inhibitor of iodide transport
(Meier and Burger 2005). We used serum coti-
nine levels to estimate tobacco smoke exposure
(Organic Analytical Toxicants Branch,
National Center for Environmental Health,
CDC). Serum lipids are generally associated
with serum organochlorine concentrations
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Table 1. Serum organochlorines in 1999–2002 NHANES participants without thyroid disease.
Percent of participants with results < LOD Median concentration (pg/g)
Organochlorine 1999–2000 cycle 2001–2002 cycle 1999–2000 cycle 2001–2002 cycle
PCB-66a NA 89 — NC
PCB-74a 47 33 41 50
PCB-99a 59 38 NC 40
PCB-105a 86 79 NC NC
PCB-118a,b 44 27 48 59
PCB-126b 36 12 0.12 0.16
PCB-138a 49 7 115 164
PCB-146a 66 53 NC NC
PCB-153a 42 4 200 234
PCB-156a,b 58 46 NC 34
PCB-169b 36 12 0.09 0.13
PCB-170a 44 25 62 74
PCB-172a NA 84 — NC
PCB-177a NA 83 — NC
PCB-178a 87 81 NC NC
PCB-180a 38 11 152 180
PCB-183a 80 70 NC NC
PCB-187a 43 34 45 51
PCB-194a NA 39 — 46
PCB-196a NA 46 — 34
PCB-201a NA 42 — 38
PCB-206a NA 89 — NC
2,3,7,8-TetraCDDb NA 88 — NC
1,2,3,7,8-PentaCDDb 83 67 NC NC
1,2,3,4,7,8-HexaCDDb NA 67 — NC
1,2,3,6,7,8-HexaCDDb 52 7 NC 0.25
1,2,3,7,8,9-HexaCDDb 82 60 NC NC
1,2,3,4,6,7,8-HeptaCDDb 28 1 0.25 0.28
1,2,3,4,6,7,8,9-OctaCDDb 22 19 1.78 2.33
2,3,4,7,8-PentaCDFb 47 35 0.03 0.03
1,2,3,4,7,8-HexaCDFb 51 18 NC 0.03
1,2,3,6,7,8-HexaCDFb 69 31 NC 0.03
2,3,4,6,7,8-HexaCDFb NA 89 — NC
1,2,3,4,6,7,8-HeptaCDFb 45 10 0.04 0.06
ΣPCBsc 32 3 — —
ΣTEQsc 80 — —
Abbreviations: —, not calculated because the congener was not measured; CDD, chlorodibenzo-p-dioxin; CDF, chloro-
dibenzofuran; NA, not tested or > 90% of results < LOD; NC, not calculated because > 50% of samples < LOD.
aCongener included in ΣPCBs. bCongener included in ΣTEQ. cPercent of participants with all congeners in ΣPCBs or
ΣTEQs < LOD.because of partitioning, and they also are often
increased in hypothyroidism. We calculated
total serum lipids using the formula given in
the NHANES laboratory manual for dioxins
(CDC 2007c): 
[Total cholesterol (mg/dL) × 2.27] 
+ triglycerides (mg/dL) + 62.3. 
Age (years), sex, race (Mexican American,
African American, Caucasian, or other), and
body mass index (BMI) were also included as
covariates. BMI was calculated from height
and weight measured during the NHANES
examination (weight in kilograms ÷ height in
meters squared). For 85 of the 91 participants
who were missing measured BMI, we imputed
BMI using self-reported weight and height. In
participants with both measures, the correla-
tion between self reported and measured BMI
was > r = 0.9. 
Statistical analyses. NHANES uses a
complex sampling design that requires the use
of sample weights to adjust for the unequal
probability of selection into the survey and to
adjust for the possible bias resulting from non-
response; weights are poststratified to U.S.
Census Bureau estimates of the U.S. popula-
tion. Data management and analyses were per-
formed with SAS 9.1 (SAS Institute Inc.,
Cary, NC), using sample weights for the indi-
vidual 2-year cycles or 4-year combined cycles,
as appropriate, and calculating variances that
accounted for the complex survey design. 
Because the data were not normally distrib-
uted, we used natural log (ln)-transformations
of TSH, ΣPCBs, ΣTEQs, DDE, BMI, and
cotinine for analysis. For univariate analyses, we
calculated means with SAS PROC SURVEY-
MEANS, using the domain command to esti-
mate means in subpopulations; differences
between groups were assessed with SAS PROC
SURVEYREG. Categorical data was evaluated
with SAS PROC SURVEYFREQ, and differ-
ences between groups were tested using SAS
PROC SURVEYLOGISTIC. 
Associations of thyroid hormones with
ΣPCBs, ΣTEQs, and DDE were modeled
using PROC SURVEYREG. SAS does not
allow for subpopulation analyses in PROC
SURVEYREG; therefore, we used Stata 6.0
(StataCorp LP, College Station, TX) to calcu-
late the variances for the subpopulation models.
Stata uses a variance estimator that accurately
measures the sample-to-sample variability of
the subpopulation estimates for the survey
design used to collect the data (StataCorp
2005). Because the ΣPCBs and ΣTEQs were
significantly higher in the second sampling
cycle (Tables 1 and 2), associations were tested
for each sampling cycle individually, using
continuous predictor variables. We could not
directly combine sampling cycles for analysis
because fewer congeners were summed and
more individual results were < LOD in the
first sampling cycle (Table 1). To combine
data from both cycles for analysis, we assumed
that the true exposure levels of the U.S. popu-
lation did not change substantially between
1999–2000 and 2001–2002, and, therefore,
that the ranks of the exposure measurements
for each cycle should be comparable. However,
ranking should be more valid for ordering par-
ticipants with high rather than low exposures,
because most of the ΣPCBs and ΣTEQs that
were composed of a large proportion of con-
geners < LOD fell into the lower ranks. Thus,
data from both sampling cycles were combined
by ranking the ΣPCB, ΣTEQ, and DDE levels
into quintiles separately for each cycle, merging
the data from both cycles, and pooling the
lowest two quintiles. Dose–response models
were estimated using indicator variables for
quintiles 3, 4, and 5, with quintiles 1 and 2
combined as the reference category, or the
ordinal variable (quintile 1–2, 3, 4, 5), to test
for a trend over the categories. For all regres-
sion analyses we used sample weights (wet
weight) of PCB, PCDD, and PCDF congeners
rather than lipid-standardized measurements,
and we included serum lipids as a covariate
(Schisterman et al. 2005).
Organochlorines and thyroid hormones
were associated with age and with many of the
potential covariates we identiﬁed prior to the
analysis. We therefore evaluated relationships
of the covariates with exposure and outcome
variables after controlling for age. TSH was
negatively associated with cotinine and post-
menopausal status, and positively associated
with BMI and use of other medications
(p < 0.05). T4 was negatively associated with
lipids, cotinine, and furosamide use, and posi-
tively associated with estrogen/progesterone
use and pregnancy (p < 0.05). At least one
exposure was positively associated (p < 0.05)
with lipids, BMI, diabetes medication use,
estrogen/progesterone use, beta-blocker use,
and postmenopausal status, and negatively asso-
ciated with steroid hormone use, other medica-
tion use, and serum cotinine. Regression
models were individually adjusted for serum
lipids, age, log BMI, race, log cotinine and
use of NSAIDs, furosemide, beta-blockers,
blood glucose regulators, other medications,
and, for women, completion of menopause.
Analyses of the combined study cycles were
also adjusted for cycle. Participants taking
estrogen and/or progesterone (n = 201) or
other steroid hormones (n = 70; 40 women
and 30 men), and pregnant participants
(n = 163) were excluded from the analyses
because potential modification of the effects
of organochlorines on thyroid hormones by
estrogen and/or progesterone medications was
noted in stratiﬁed analyses.
Results
Demographic information, medication use,
and thyroid hormone levels for participants
without thyroid disease are shown in Table 3.
Total T4 was higher in females than males, but
TSH did not differ by sex (Table 3). T4 was
higher and TSH was lower in the 2001–2002
cycle compared with the 1999–2000 cycle
(p < 0.05; data not shown). BMI, lipids, TSH,
percent with TSH > 5.0 IU/L, and use of
medications (estrogens and/or progesterones,
other steroid hormones, beta-blockers,
NSAIDs, and blood glucose regulators)
increased with age, whereas cotinine exposure
decreased with age (p < 0.05; data not shown). 
ΣPCBs, ΣTEQs, and DDE were positively
associated with age in males and females
(p < 0.05), but mean levels did not differ sig-
niﬁcantly by sex (p > 0.05; data not shown).
Correlations among organochlorines were posi-
tive, with the strongest associations between
ΣPCBs and ΣTEQs (range, r = 0.44–0.82).
The main congeners contributing to ΣPCBs
were PCBs 138, 153, and 180, which com-
prised 54% and 41% of the ΣPCBs in the ﬁrst
and second cycles, respectively, with these indi-
vidual congeners highly correlated with ΣPCBs
(r = 0.90–0.99). Approximately 76% of
ΣTEQs were from the congeners 1,2,3,7,8-
pentaCDD, 1,2,3,6,7,8-hexaCDD, 2,3,4,7,8-
pentaCDF, and PCB-126 in cycle 1 and from
these four congeners plus 2,3,7,8-tetraCDD in
cycle 2. TEQs for these congeners were signiﬁ-
cantly associated with ΣTEQs (r = 0.71–0.89),
with stronger associations in the second cycle
than the ﬁrst cycle. Because both ΣPCBs and
ΣTEQs were higher in the second cycle than in
the ﬁrst cycle (Table 2), we ﬁrst modeled the
relationships of these organochlorines with thy-
roid hormones separately for each sampling
cycle (Tables 4 and 5). 
Thyroid function and PCBs, dioxins, and DDE in adults
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Table 2. Serum ΣPCBs, ΣTEQs, and DDE levels in 1999–2002 NHANES participants without thyroid disease.
1999–2000 cycle 2001–2002 cycle
Organochlorine No. GMa 95% CI No. GMa 95% CI
ΣPCBs (ng/g) 945 0.86* 0.81–0.92 1,406 1.27* 1.20–1.35
ΣPCBs (ng/g lipid) 945 139.8* 132.1–147.9 1,406 200.3* 189.3–212.1
ΣTEQs (pg/g) 877 0.08* 0.07–0.08 1,107 0.12* 0.11–0.13
ΣTEQs (pg/g lipid) 877 12.3* 11.6–13.0 1,107 18.2* 16.6–19.9
DDE (ng/g) 986 1.82 1.53–2.17 1,443 2.12 1.91–2.35
DDE (ng/g lipid) 986 293.0 248.0–346.1 1,443 337.0 304.3–373.1
GM, geometric mean.
aAll estimates were adjusted for survey design and sample weights. *Signiﬁcantly different by study cycle (p < 0.05).Total T4 was negatively associated with
total ΣTEQs in men and women, with
stronger associations of T4 with ΣTEQs for
both men and women in the second sampling
cycle compared with the ﬁrst cycle (Tables 4
and 5). Results, however, were statistically sig-
nificant only in older women and men; in
older men the results were inconsistent and
were statistically signiﬁcant only in the second
cycle with further adjustment for ΣPCB and
DDE levels. In women, TSH was positively
associated with ΣTEQs, with a statistically
signiﬁcant association only in older women in
the second sampling cycle. In men, associa-
tions of TSH with ΣTEQs were generally
negative, but not signiﬁcant. 
Associations of ΣPCBs with T4 and TSH
were inconsistent in women. In older women,
ΣPCBs were negatively associated with T4
and positively associated with TSH, with
statistically signiﬁcant associations only in the
second cycle (Table 4). In men, TSH was
negatively associated with ΣPCBs; associa-
tions were statistically signiﬁcant in older men
during the first cycle and during the second
cycle with further adjustment for ΣTEQs and
DDE. Associations of T4 with ΣPCBs in men
were inconsistent and were not statistically
signiﬁcance (Table 5).
T4 was positively associated with DDE in
all women and in younger women, with a sta-
tistically signiﬁcant association only in the ﬁrst
cycle in younger women. In older women, the
direction of the association differed by cycle
(Table 4). In men, T4 was negatively, but not
signiﬁcantly, associated with DDE; again the
direction of the association differed in older par-
ticipants (Table 5). Associations of TSH with
DDE were inconsistent and not signiﬁcant.
Data from both sampling cycles were
combined by ranking the exposure measure-
ments into quintiles for each individual cycle,
merging the data from both cycles, and com-
bining the lowest two quintiles. We found a
dose response for the associations of ΣTEQs
with T4 for women and men, with a signifi-
cant trend for the dose only for women
(Figure 1). The decrease in total T4 with an
increase in one quintile of ΣTEQs was
0.25 µg/dL [95% confidence interval (CI),
0.02–0.48] for women. The T4 decrease was
0.75 µg/dL (95% CI, 0.04–1.46) for women
in the highest TEQ quintile compared with
the lowest. The association for women
remained significant or of borderline signifi-
cance with further adjustment for quintile
ΣPCBs or quintile DDE. No other signiﬁcant
associations were found for the combined data
cycles for T4 with PCBs or DDE or for TSH
with any exposure in either men or women.
We repeated the analyses using a different
method to calculate ΣPCBs and ΣTEQs.
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Table 3. Characteristics of the 1999–2002 NHANES participants without thyroid disease.a
Males Females
Characteristic Estimateb 95% CI Estimateb 95% CI
No. 1,166 1,279
Ethnicity (%)*
Caucasian 72.5 67.4–77.7 68.8 63.9–73.6
African American 9.4 6.6–12.1 11.5 7.9–15.1
Mexican American 8.5 5.9–11.1 7.3 5.1–9.5
Other/mixed 9.6 5.5–13.6 12.4 8.6–16.3
Age [mean (years)]  44.9 43.6–46.3 45.9 44.6–47.1
BMI [geometric mean (kg/m2)] 27.3 26.9–27.8 27.0 26.5–27.5
Total serum lipids [mean (mg/dL)] 683* 660–707 652* 639–665
Cotinine [geometric mean (ng/mL)] 1.2* 0.8–1.8 0.4* 0.3–0.5
Completed menopause (%) NA 45.5 41.9–49.1
Pregnant (%) NA 3.7 2.6–4.7
Medication use in the past month (%)
Estrogen and/or progesterone  NA 21.3 16.9–25.7
Other steroid hormones  2.3 1.1–3.4 3.2 2.3–4.1
Furosamide 2.2 1.1–3.4 2.7 1.7–3.8
Beta-blockers 6.7 4.0–9.5 5.6 4.3–6.9
NSAIDs 25.9 22.0–29.8 26.4 22.0–30.8
Blood glucose regulators 5.6 3.9–7.2 4.4 3.0–5.9
Other drugsc 0.8 0.3–1.3 1.0 0.3–1.7
Thyroid hormones
T4 [mean (µg/dL)] 7.5* 7.3–7.7 8.2* 8.0–8.5
T4 [< 5.4 µg/dL (%)] 8.0* 5.3–10.6 3.2* 1.5–5.0
T4 [> 12.8 µg/dL (%)] 0.1* 0.0–0.2 1.5* 0.7–2.3
TSH [geometric mean (IU/L)] 1.44 1.39–1.50 1.46 1.39–1.53
TSH [< 0.47 IU/L (%)] 2.9 1.5–4.2 3.8 2.7–5.0
TSH [> 5.0 IU/L (%)] 2.4 1.4–3.5 2.3 1.4–3.2
NA, not applicable. Data were missing for cotinine (n = 21), BMI (n = 4), TSH (n = 3), pregnancy (n = 10), and completion of
menopause (n = 25).
aA total of 36 men and 114 women with thyroid disease (reported current thyroid disease or taking thyroid medications)
were excluded from the analysis. bAll estimates were adjusted for survey design and sample weights. cIncludes ami-
doarone, carbamazepine, chlorpropamide, carbidopa/levodopa, heparin, interferon, lithium, phenytoin, phenobarbital, or
sulfasalazine. *Signiﬁcantly different by sex, p < 0.05.
Table 4. Associations [β (95% CI)] of ΣTEQs and ΣPCBs with thyroid hormones in women without thyroid disease.
Association of total T4 with Association of Ln TSH with
Subgroup, cycle Ln ΣPCBs Ln ΣTEQs Ln DDE Ln ΣPCBs Ln ΣTEQs Ln DDE
All women
1999–2000 –0.20 (–0.47 to 0.07) –0.19 (–0.70 to 0.33) 0.16a (–0.04 to 0.37) –0.03 (–0.30 to 0.25) 0.15 (–0.14 to 0.44) –0.01 (–0.12 to 0.11)
n = 333  n = 310  n = 350  n = 332  n = 309  n = 350 
2001–2002 0.09 (–0.42 to 0.59) –0.58* (–1.26 to 0.10) 0.11 (–0.07 to 0.30) 0.01 (–0.17 to 0.19) 0.06 (–0.15 to 0.27) 0.08 (–0.03 to 0.19)
n = 476  n = 386  n = 490  n = 475  n = 385  n = 489 
Women < 60 years of age
1999–2000 –0.08 (–0.40 to 0.25) –0.04 (–0.78 to 0.69) 0.33a,** (0.04 to 0.62) –0.04 (–0.36 to 0.28) 0.16 (–0.14 to 0.47) –0.04 (–0.16 to 0.08)
n = 215  n = 197  n = 219  n = 214  n = 196  n = 219 
2001–2002 0.20 (–0.35 to 0.76) –0.51 (–1.30 to 0.29) 0.08 (–0.14 to 0.29) –0.01 (–0.21 to 0.19) 0.04 (–0.27 to 0.35) 0.09 (–0.05 to 0.22)
n = 327  n = 260  n = 337  n = 326  n = 259  n = 336 
Women > 60 years of age
1999–2000 –0.38 (–0.89 to 0.14) –0.40** (–0.71 to –0.10) –0.47a,# (–0.74 to –0.20) 0.14 (–0.17 to 0.45)  0.00 (–0.48 to 0.48) 0.15a,* (–0.01 to 0.30)
n = 118  n = 113  n = 131  n = 118  n = 113  n = 131 
2001–2002 –0.96a,# (–1.51 to –0.41) –1.20a,# (–1.75 to –0.64) 0.26a,* (–0.03 to 0.55) 0.25** (0.05 to 0.46) 0.23** (0.04 to 0.42) 0.05 (–0.04 to 0.15)
n = 149  n = 126  n = 153  n = 149  n = 126  n = 153 
Value for the effect of ΣPCBs, ΣTEQs, or DDE individually on thyroid hormone is from the linear regression model adjusted for survey design and sample weights, total serum lipids, BMI,
race, age, log serum cotinine, menopausal status, and medication use (furosamide, NSAIDs, beta-blockers, blood glucose regulators, and other medications). Effects of organochlorines
on thyroid hormones were also estimated in linear regressions that simultaneously modeled for concentrations of ΣPCBs, ΣDDE, and TEQs, and the signiﬁcance of the effects but not the
beta coefﬁcients are shown.
aFor model including all three organochlorines, p < 0.05. *0.05 < p < 0.1, **0.01 < p < 0.05, and #p < 0.01 for model using individual organochlorine. Only congeners detectable in > 50% of partic-
ipants were included in the ΣPCBs and
ΣTEQs (Table 1). Results were generally simi-
lar for the analyses of data from the individual
cycles, except T4 was not signiﬁcantly associ-
ated with ΣTEQs in older women in the ﬁrst
cycle, and T4 became signiﬁcantly associated
with ΣTEQs in older men in the second cycle
(data not shown). In the combined cycle
analysis, the association of ΣTEQs with T4
was slightly weaker in women and slightly
stronger in men (0.05 < p < 0.15 for both;
data not shown). In older men, the association
of ΣPCBs with TSH in the ﬁrst cycle did not
remain signiﬁcant (data not shown).
Because these data are a sample from the
general population, we would expect that some
participants might have unusually high conta-
minant exposures due to high sport ﬁsh con-
sumption or occupation and abnormal thyroid
hormone levels because of undiagnosed thyroid
disease. To determine if model results were
affected by extreme values, we excluded partici-
pants with exposure values more than three
interquartile ranges above the 75th percentile
(ΣPCBs > 7 ng/g, n = 25; ΣTEQs > 0.62 pg/g,
n = 20; DDE > 30 ng/g, n = 78) and partici-
pants with very high TSH (42.7, 44.0, 81.9,
234.6 IU/L) and T4 levels (27 µg/dL).
Signiﬁcant relationships between thyroid hor-
mones and ΣTEQs remained. For men
> 60 years of age, the negative association of
ΣPCBs with TSH became significant in the
second sampling cycle, but did not remain sig-
niﬁcant in the ﬁrst sampling cycle; for women
> 60 years of age in the second sampling cycle,
the positive association of ΣPCBs with TSH
did not remain signiﬁcant (data not shown). 
Discussion
In the adult participants of NHANES
from 1999 to 2002, total T4 was negatively
associated with serum dioxin-like TEQs in a
dose-dependent fashion, with stronger associa-
tions in women than men. Associations of
organochlorines with thyroid hormones were
stronger in participants > 60 years of age, with
lower T4 and higher TSH with both PCB and
TEQ exposure in women, and lower TSH
with PCB exposure in men. With further
adjustment for multiple exposures, the nega-
tive associations of T4 with TEQs generally
remained signiﬁcant or borderline signiﬁcant. 
Overall, results of human studies on the
effects of PCBs, PCDDs, and DDE on thyroid
hormones have been inconsistent. However, a
variety of factors may be related to the incon-
sistent ﬁndings, the most important of which
may include small numbers of participants,
varying overall exposure levels, use of various
detection methods for biomarkers and endoge-
nous hormones, and differing age, sex, and
unmeasured exposures to chemicals affecting
hormone homeostasis. 
In three studies with high exposures,
dioxin-like chemicals have been associated with
increased thyroid hormones. Occupational
exposures to dioxin-like compounds were asso-
ciated with increased levels of free T4 (mean
220 pg/g lipid TEQ; Calvert et al. 1999), as
well as total T4 and thyroxine-binding globulin
(range, < 1–533 pg/g lipid TEQ; Ott et al.
1994). Exposure to PCBs and PCDFs in the
Yusho outbreak was associated with increased
total triiodothyroxine (T3) and T4, but not
TSH, 16 years after exposure (Murai et al.
1987), with a mean of 222.4 pg/g lipid TEQ
30 years after exposure (Nagayama et al. 2001).
Results have varied more for lower exposures:
with no association with total T4 or TSH in
metal recyclers (mean, 42 pg/g lipid TEQ;
Treibig et al. 1998); increased TSH but no
change in total T4 in Vietnam veterans (mean,
45.7 pg/g lipid TEQ; Pavuk et al. 2003),
decreased TSH but no association with total
T3, total T4 or free T4 in male ﬁsh consumers
(range, 11–105 pg/g lipid TEQ; Turyk et al.
2006a), and decreased total T3 and total T4,
but no change in TSH and free T4, in pregnant
women (mean, 74.9 pg/g lipid TEQ in breast
milk; Koopman-Esseboom et al. 1994). The
differential effects of dioxins on thyroid hor-
mone homeostasis that appear to be related to
exposure levels could potentially be attributed
to down-regulation of the AhR after large expo-
sures, such as noted after the Seveso (Italy) acci-
dent (Landi et al. 2003). In the present study,
with an average TEQ exposure of 12–18 pg/g
lipid, we observed decreased T4 with dioxin-like
exposure, in agreement with Koopman-
Esseboom et al. (1994). 
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Table 5. Associations [β (95% CI)] of ΣTEQs and PCBs with thyroid hormones in men without thyroid disease.
Association of total T4 with Association of Ln TSH with
Subgroup, cycle Ln ΣPCBs Ln ΣTEQs Ln DDE Ln ΣPCBs Ln ΣTEQs Ln DDE
All men
1999–2000 0.12 (–0.30 to 0.55) –0.12 (–0.61 to 0.37) –0.08 (–0.35 to 0.19) –0.17 (–0.45 to 0.11) –0.09 (–0.38 to 0.20) –0.05 (–0.11 to 0.01)
n = 436  n = 402 n = 454 n = 436 n = 402 n = 454
2001–2002 –0.31 (–0.76 to 0.15) –0.47* (–0.97 to 0.04) –0.03 (–0.18 to 0.24) –0.09 (–0.21 to 0.04) –0.02 (–0.20 to 0.16) 0.04 (–0.03 to 0.10)
n = 653  n = 497 n = 667 n = 653 n = 497 n = 667
Men < 60 years of age
1999–2000 –0.06 (–0.70 to 0.57) –0.27 (–0.79 to 0.26) –0.10 (–0.39 to 0.18) –0.15 (–0.54 to 0.24) –0.05 (–0.39 to 0.29) –0.04 (–0.11 to 0.03)
n = 278  n = 252 n = 286 n = 278 n = 252 n = 286
2001–2002 –0.41 (–0.92 to 0.10) –0.40 (–1.05 to 0.25) –0.02 (–0.26 to 0.22) –0.09 (–0.24 to 0.06) –0.12 (–0.38 to 0.14) 0.02 (–0.05 to 0.09)
n = 467  n = 342 n = 472 n = 467 n = 342 n = 472
Men > 60 years of age
1999–2000 0.19 (–0.36 to 0.74) 0.25 (–0.36 to 0.86) –0.18a (–0.47 to 0.11) –0.19** (–0.38 to 0.00) –0.22 (–0.54 to 0.10) –0.09 (–0.25 to 0.08)
n = 158  n = 150 n = 168 n = 158 n = 150 n = 168
2001–2002 0.10 (–0.61 to 0.81) –0.57a,* (–1.17 to 0.32) 0.21 (–0.19 to 0.60) –0.18a,* (–0.37 to 0.01) 0.19 (–0.11 to 0.49) 0.10 (–0.06 to 0.26)
n = 186  n = 155 n = 195 n = 186 n = 155 n = 195
Value for the effect of ΣPCBs, ΣTEQs, or DDE individually on thyroid hormone is from the linear regression model adjusted for survey design and sample weights, total serum lipids, BMI, race,
age, log serum cotinine, and medication use (furosamide, NSAIDs, beta-blockers, blood glucose regulators, and other medications). Effects of organochlorines on thyroid hormones were also
estimated in linear regressions that simultaneously modeled for concentrations of ΣPCBs, ΣDDE, and TEQs, and the signiﬁcance of the effects but not the beta coefﬁcients are shown. 
aFor model including all three organochlorines, p < 0.05. *0.05 < p < 0.1, and **p < 0.05 for model using individual organochlorine.
Figure 1. Associations [β (95% CI)] of total T4 with
ΣTEQs in participants from both the 1999–2000 and
the 2001–2002 NHANES cycles. ΣTEQs were ranked
into quintiles within each individual cycle, the cycles
were merged, and the lowest two quintiles were
combined for analysis. Models were adjusted for
survey design, sample weights, study cycle, total
serum lipids, log BMI, race, age, log serum cotinine,
medication use (furosamide, NSAIDs, beta-blockers,
blood glucose regulators, and other medications),
and menopause status (women only). Adjusted beta
coefficients (95% CIs) for trends across quintiles
were –0.09 (–0.28 to 0.10) for men (p = 0.28, n = 899)
and –0.25 (–0.48 to –0.02) for women (p = 0.03,
n = 696). With further control for DDE, trend across
quintiles remained signiﬁcant for women (p < 0.05).
With further control for ΣPCBs, results were of
borderline signiﬁcance for women (p = 0.07).
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Most studies of exposure to PCBs have
found inverse associations with T4. A negative
association with one or more thyroid hormones
and positive associations with TSH have been
found with measures of PCB exposure in chil-
dren living near PCB-contaminated sites
(Osius et al. 1999; Schell et al. 2004). Langer
et al. (1998) reported that PCB production
workers and controls from a less-polluted area
had similar levels of total T4 and TSH, but a
later study of adults from a heavily polluted
area demonstrated positive relationships of
PCBs with free T4 and free T3 (Langer et al.
2004). Male capacitor manufacturing employ-
ees with exposure to PCBs and chlorinated
naphthalene had decreased TSH and no
change in total T4 (Persky et al. 2002). In fre-
quent ﬁsh consumers, an inverse association of
PCB-153 was found with total T3 among
women (Hagmar et al. 2001b) but not men
(Hagmar et al. 2001a; Rylander et al. 2006).
In a group of frequent Great Lakes ﬁsh con-
sumers, Persky et al. (2001) found inverse
associations of PCB levels with total T4 in
men and women and with free T4 in women;
in a different subgroup of participants from
the same study, inverse associations of PCBs
were found with total T3, total T4, and TSH
in men (Turyk et al. 2006a). Much smaller
effects of PCBs on thyroid hormones were
noted in New York anglers (Bloom et al.
2003) and in a population in Spain (Sala et al.
2001). Negative associations were found for
total T3 with low-level exposure to PCBs in
pregnant women (Takser et al. 2005); negative
associations were also found in men (Meeker
et al. 2007), but only after controlling for
DDE. In the present study we saw no effect of
PCBs on thyroid hormones in the NHANES
cohort as a whole, although we did find
decreased T4 and increased TSH in older
women and decreased TSH in older men. It is
possible that there were effects on unmeasured
thyroid hormones, such as free T4 or total T3,
or that levels of PCBs were too low to affect
thyroid homeostasis.
Few investigations have examined associa-
tions of DDE with thyroid hormones. No
associations were found for DDE with thyroid
hormones in male or female fish consumers
(Hagmar et al. 2001a; Persky et al. 2001;
Turyk et al. 2006a); a positive association was
found with TSH in male fish consumers
(Rylander et al. 2006); a negative association
was found with total T3 in pregnant women
with low levels of exposure (Takser et al.
2005); and positive associations were found
with total T3 and free T4 in men with low
exposure (Meeker et al. 2007). In the present
study, we did not ﬁnd any signiﬁcant associa-
tions of DDE with thyroid hormones when
both sampling cycles were combined, although
T4 was positively associated with DDE in
younger women, but only in the ﬁrst sampling
cycle. In older participants, associations in the
ﬁrst and second cycles were inconsistent. 
The HPT axis normally responds to
decreases in free T4 with increased production
of TSH. In women > 60 years of age, we found
that PCBs and TEQs were negatively associ-
ated with T4 and positively associated with
TSH, which is consistent with a normal pitu-
itary response to decreased T4 levels. Elevated
TSH, even within the high-normal reference
range, may be a marker for increased risk of
hypothyroidism (Vanderpump 2005). In
adults living in areas with sufficient iodide
intake, the most common cause of hypo-
thyroidism is autoimmune disease. Markers of
autoimmune disease, such as anti-thyroperoxi-
dase antibodies and thyroid hypoechogenicity,
have been associated with PCB exposure
(Langer et al. 2004, 2007). Our observation of
decreased T4 and increased TSH in older
women with higher exposure to dioxin-like
TEQs or PCBs is intriguing because this popu-
lation group has the highest risk of hypo-
thyroidism, reaching an annual incidence rate
of > 13/1,000 in women 75–80 years of age
(Vanderpump 2005). The NHANES data set
did not provide sufficient information on
diagnosis of hypothyroidism to allow us to
study the effects of organochlorine exposure
on the prevalence of hypothyroidism. Overall,
the decreases in T4 noted in this analysis may
or may not be significant on an individual
level, but they could substantially contribute
to disease burden in the population. 
Associations of organochlorines with thy-
roid hormones in the present study were
stronger in females than in males, similar to
results in studies of ﬁsh consumers (Hagmar
et al. 2001a, 2001b; Persky et al. 2001), in
children 7–10 years of age (Osius et al. 1999),
and in infants (Wang et al. 2005). The
stronger effects of organochlorines, particularly
in older females, could be related to a number
of age and/or sex-associated factors, including
hormonal environment, organochlorine expo-
sure and metabolism, and risk of developing
preclinical and clinical thyroid disease. In these
NHANES participants, PCBs and dioxin-like
congeners differed by sex, with females having
greater levels of dioxin-like congeners than
males (Needham et al. 2005), which may be
related to differential metabolism or elimina-
tion inﬂuenced by body fat or hormonal fac-
tors (Geyer et al. 2002). 
Levels of PCBs, TEQs, and DDE in the
NHANES participants in the 2001–2002 cycle
were similar to those found in infrequent
sport-ﬁsh consumers (Turyk et al. 2006b) and
to age-specific PCDD, PCDF, and coplanar
PCB TEQs in various U.S. populations
(Patterson et al. 2004). PCBs and TEQs were
signiﬁcantly lower in participants during the
1999–2000 cycle than the 2001–2002 cycle,
which limited our ability to draw conclusions
about effects of these organochlorines on hor-
mones for 1999–2000. Misclassification is
more likely in the participants with lower levels
of exposure because of the larger number of
results < LOD, caused in part by laboratory
limitations related to small serum volumes
(Needham et al. 2005). We examined data
from both cycles simultaneously to increase
our power to detect sex-specific associations.
To this end, we ranked both cycles into quin-
tiles, merged them, and pooled the lowest two
quintiles for analysis; although some residual
misclassiﬁcation may be present in this analy-
sis, the results for TEQs and T4 are consistent
with those found in the analyses of the second
cycle alone. The inconsistencies in associations
of DDE with thyroid hormones cannot be
explained by differences in exposure levels by
study cycle. An additional source of measure-
ment error could come from the change in the
laboratory performing the hormone tests dur-
ing the second cycle, although the CDC has
determined that values for TSH and T4 are
comparable across the second cycle (Blount
et al. 2006). In addition, any misclassiﬁcation
of the hormone levels in the second cycle
should be nondifferential with regard to expo-
sure and thus would be more likely to weaken
associations in the second cycle. In fact, we saw
stronger organochlorine–hormone associations
in the second cycle compared with the ﬁrst.
The cross-sectional design of the present
study limits our ability to evaluate the tempo-
ral association of organochlorine exposure
with thyroid hormone changes, but generally
concentrations of organochlorines reﬂect long-
term exposures with many congeners, particu-
larly the more highly chlorinated congeners,
persisting for years within the body (Geyer
et al. 2002). We adjusted for many biological
factors that could influence the relationship
between thyroid hormones and organochlo-
rines, but thyroid hormones affect several
aspects of metabolism; thus, there may be
other factors related to both serum levels of
organochlorines and thyroid hormones for
which we have not controlled. Additional hor-
mone measurements, such as T3, free T4, and
thyroxine-binding globulin, might have helped
to elucidate mechanisms related to the associa-
tions we found between TEQs and thyroid
hormones. In addition, the decreases in T4
could be associated with other unmeasured
exposures, such as polybrominated biphenyl
ethers or PCB metabolites, which are associ-
ated with the measured organochlorines.
Although our main findings generally
remained signiﬁcant or borderline signiﬁcant
after adjustment for other measured organo-
chlorines, evaluation of the effects of multiple
exposures can be imprecise because of strong
associations among exposures. Finally, the
results for the subpopulation analyses should
be viewed with caution in consideration of thesample size, which may be too small to produce
reliable estimates using population-based statis-
tical methodology.
In spite of the limitations and issues
related to sample analysis for organochlorines
and thyroid hormones described above, the
present study has a number of strengths,
including generally similar trends for results in
both sampling cycles for the primary ﬁndings,
large number of participants, population-
based sampling design, and consistency with
results of toxicologic studies in animals.
Despite the fact that decreases of PCBs and/or
PCDDs over time have been noted in cross-
sectional and longitudinal studies (Hagmar
et al. 2006; Schecter et al. 2005), the U.S.
population continues to be exposed to low lev-
els of these persistent chemicals, primarily
through a dietary route. The data show a dose-
dependent decrease in total T4 with exposure
to dioxin-like TEQs, with an average decrease
of 0.75 µg/dL, or 9% of average T4 levels, in
the highest quintile compared with the lowest
quintile in women, and suggests that older
adults, who have a high risk of thyroid disease,
may be more at risk for disruption of thyroid
hormone homeostasis by organochlorines than
younger adults.
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